Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study

Overview of attention for article published in Frontiers in immunology, August 2022

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 18 publications that cite this research output.

18

The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.

Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine

Article in iScience (July 2024)

Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial

Article in Vaccines (June 2024)

A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2

Article in Antiviral Research (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.